Sloane Robinson’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Sloane Robinson’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-57,500	Closed	-$2.23M	–	14
2015 Q1	$2.23M	Sell	57,500 -49,900	-46%	-$1.92M	3.35%	4
2014 Q4	$3.62M	Sell	107,400 -12,600	-11%	-$445K	6.28%	6
2014 Q3	$4.2M	Hold	120,000	–	–	6.01%	5
2014 Q2	$3.94M	Sell	120,000 -40,100	-25%	-$1.37M	2.47%	8
2014 Q1	$5.9M	Sell	160,100 -87,600	-35%	-$3.21M	3.5%	8
2013 Q4	$9.51M	Sell	247,700 -55,400	-18%	-$1.75M	5.56%	5
2013 Q3	$8.3M	Buy	+303,100	New	+$7.18M	7.08%	6

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Sloane Robinson's WX Position: Q2 2015 in Review

Sloane Robinson sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2015, closing a stake of 57,500 shares — an estimated $2.23M sold.

Sloane Robinson first reported a position in WX in Q3 2013 and held it in 7 quarters. The position peaked at $9.51M in Q4 2013. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

Sloane Robinson reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2015 after selling out during the quarter.
Sloane Robinson sold 57,500 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $2.23M.
Sloane Robinson first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 7 quarters.
Sloane Robinson's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $9.51M in Q4 2013.
154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on Sloane Robinson's 13F filing for Q2 2015, filed 10 Aug 2015.